Cytokine Induction of the Ability of Human Monocyte CD44 to Bind Hyaluronan is Mediated Primarily by TNF-α and is Inhibited by IL-4 and IL-13

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6184-6194

  Levesque, Marc C ^a   Haynes, Barton F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING COMPETITION; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MONOCYTE; PHYSIOLOGY;

ANTIGENS, CD44; BINDING, COMPETITIVE; CELLS, CULTURED; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYALURONIC ACID; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-3; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031573628     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Haynes, B. F., M. J. Telen, L. P. Hale, and S. M. Denning. 1989. CD44: a molecule involved in leukocyte adherence and T cell activation. Immunol Today 10:423.
2. Stamenkovic, I., M. Amiot, J. M. Pesando, and B. Seed. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057.
3. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
4. Miyake, K., C. B. Underhill, J. Lesley, and P. W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69.
5. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271.
6. Huet, S., H. Groux, B. Caillou, H. Valentin, A. M. Prieur, and A. Bernard. 1989. CD44 contributes to T cell activation. J. Immunol. 143:798.
7. Shimizu, Y., G. A. Seventer, R. Siraganian, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143: 2457.
8. Denning, S. M., P. T. Le, K. H. Singer, and B. F. Haynes. 1990. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144:7.
9. Pierres, A., C. Lipcey, C. Mawas, and D. Olive. 1992. A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur. J. Immunol. 22:413.
10. Rothman, B. L., M. L. Blue, K. A Kelley, D. Wunderlich, D. V. Mierz, and T. M. Aune. 1991. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J. Immunol. 147:2493.
11. Naujokas, M. F., M. Morin, M. S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257.
12. Tan, P. H., E. B. Santos, H. C. Rossbach, and B. M. Sandmaier. 1993. Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 150:812.
13. Webb, D. S., Y. Shimizu, G. A. van Seventer, S. Shaw, and T. L. Gerrard. 1990. LFA-3, CD44 and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295.
14. Noble, P. W., F. R. Lake, P. M. Henson, and D. W. H. Riches. 1993. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J. Clin. Invest. 91:2368.
15. Hiro, D., A. Ito, K. Matsuta, and Y. Mori. 1986. Hyaluronic acid is an endogenous inducer of interleukin-1 production by human monocytes and rabbit macrophages. Biochem. Biophys. Res. Commun. 140:715.
16. Mckee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Stricter, C. Bao, and P. W. Noble. 1996. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. J. Clin. Invest. 98:2403.
17. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993 T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361:79.
18. Bennett, K. L., D. G. Jackson, J. C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687.
19. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopomin (Eta-1). Science 271:509.
20. Culty, M., H. A. Nguyen, and C. B. Underhill. 1992. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1055.
21. Underhill, C. B., H. A. Nguyen, H. A., M. Shizari, and M. Culty. 1993. CD44 positive macrophages take up hyaluronan during lung development. Dev. Biol. 155:324.
22. DeGrendele, H. C., P. Estess, L. J. Picker, and M. H. Siegelman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183:1119.
23. Koopman, G., Y. van Kooyk, M. de Graaff, C. J. Meyer, C. G. Figdor, and S. T. Pals. 1990. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol. 145:3589.
24. Conrad, P., B. L. Rothman, K. A. Kelley, and M. L. Blue. 1992. Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J. Immunol. 149:1833.
25. Haynes, B. F., L. P. Hale, K. L. Patton, M. E. Martin, and R. M. McCallum. 1991. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: upregulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 34:1434.
26. Hale, L. P., B. F. Haynes, and S. S. McCachren. 1995. Expression of CD44 variants in human inflammatory synovitis. J. Clin. Immunol. 15:300.
27. Mikecz, K., F. R. Brennan, J. H. Kim, and T. T. Giant. 1995. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558.
28. Lesley, J., R. Schulte, and R. Hyman. 1990. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187:224.
29. Lesley, J., Q. He, K. Miyake, A. Hamann, R. Hyman, and P. W. Kincade. 1992. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175:257.
30. Lesley, J., P. W. Kincade, and R. Hyman. 1993. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol. 23:1902.
31. Liao, H. X., M. C. Levesque, K. Patton, B. Bergamo, D.M. Jones, M. J. Moody, M. Telen, and B. B. Haynes. 1993. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol. 151:6490.
32. Levesque, M. C., and B. F. Haynes. 1996. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J. Immunol. 156:1557.
33. Murakami, S., K. Miyake, C. H. June, P. W. Kincade, and R. J. Hodes. 1990. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145: 3618.
34. Lazaar, A. L., S. M. Albelda, J. M. Pilewski, B. Brennan, E. Pure, and R. A. Panettieri. 1994. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 180:807.
35. Howard, M. C., A. Miyajima, and R. Coffman. 1993. T-cell-derived cytokines and their receptors. In Fundmental Immunology, 3rd Ed. William E. Paul, ed. Raven Press, Ltd., New York, p. 263.
36. Cavaillon, J. M. 1994. Cytokines and macrophages. Biomed. Pharmacother. 48: 445.
37. Durum, S. K., and J. J. Oppenheim. 1993. Proinflammatory cytokines and immunity. In Fundamental Immunology, 3rd Ed. William E. Paul, ed. Raven Press, Ltd., New York, p. 263.
38. Telen, M. J., G. S. Eisenbarth, and B. F. Haynes. 1983. Human erythrocyte antigens: regulation of expression of a novel red cell surface antigen by the inhibitor Lutheran In(Lu) gene. J. Clin. Invest. 71:1878.
39. Liao, H-X., D. M. Lee, M. C. Levesque, and B. F. Haynes. 1995. N-terminal and central region of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J. Immunol. 155:3938.
40. MacKay, C. R., H. J. Terpe, R. Stauler, W. L. Manston, H. Stark, and U. Gunthert. 1994. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124:71.
41. de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. deVries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol. 151:6370.
42. Yano, S., S. Sone, Y. Nishioka, N. Mukaida, K. Matsushima, and T. Ogura. 1995. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor. J. Leukocyte Biol. 57:303.
43. Peach, R. J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257.
44. Yang, B., B. L. Yang, R. C. Savani, and E. A. Turley. 1994. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:286.
45. Kohda, D., C. J. Morton, A. A. Parkar, H. Hatanaka, and F. M. Inagaki. 1996. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86:767.
46. Bourguignon, L. Y. W., V. B. Lokeshwar, X. Chen, and W. G. L. Kerrick. 1993. Hyaluronic acid-induced lymphocyte signal transductions and HA receptor-cytoskeletal interaction. J. Immunol. 151:6634.
47. Chiu, R. K., A. Droll, D. L. Cooper, S. T. Dougherty, J. F. Dirks, and G. J. Dougherty. 1995. Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44. J. Neurooncol. 26:231.
48. Hale, L. P., K. H. Singer, and B. F. Haynes. 1989. CD44 antibody against In(Lu)-related p80, lymphocyte homing receptor molecule inhibits the binding of human erythrocytes to T cells. J. Immunol. 143:3944.
49. Wells, A. F., L. Klareskog, S. Lindblad, and T. C. Laurent. 1992. Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. Arthritis Rheum. 35:391.
50. Butler, D. M., G. F. Vitti, T. Leizer, and J. A. Hamilton. 1988. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombination human tumor necrosis factor α, tumor necrosis factor β (lymphotoxin), interleukin-1α, and interleukin-1β. Arthritis Rheum. 31:1281.
51. D'Silva, H., T. Yoshida, and S. Cohen. 1983. The effect of lymphokines on macrophage accumulation and disappearance in the peritoneal cavity. J. Exp. Pathol. 1:61.
52. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, and H. Bijl. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
53. Van Dillemen, H. M., S. J. H. Deventer, D. W. Hommes, H. A. Bijl, J. Jansen, G. N. J. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129.
54. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for tumor necrosis factor α in the syndrome of cachexia, arthritis and autoimmunity resulting from tristetraprolin deficiency. Immunity 4:445.
55. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias. 1991. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10:4025.
56. Firestein, G. S. 1995. Cytokine networks in rheumatoid arthritis: implications for therapy. Agents. Actions. Suppl. 47:37.
57. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
58. McInnes, I. B., B. P. Laung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. IL-15 mediates T cell dependent regulation of TNF-γ in RA. Nat. Med. 3:189.
59. Keegan, A. D., J. J. Ryan, and W. E. Paul. 1996. IL-4 regulates growth and differentiation by distinct mechanisms. The Immunologist 4:194.
60. Weinberg, J. B., T. S. Wortham, M. A. Misukonis, and K. L. Patton. 1993. Synovial mononuclear phagocytes in rheumatoid arthritis and osteoarthritis: quantitative and functional aspects. Immunol. Invest. 22:365.
61. Del Prete, G., M. De Carli, R. M. Lammel, M. M. D'Elios, K. C. Daniel, B. Giusti, R. Abbate, and S. Romagnani. 1995. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250.
62. Walmsley, M., P. D. Katsikis, E. Abney, S. Parry, R. O. Williams, R. N. Maini, and M. Feldman. 1996. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:495.
63. Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkowski, and S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-1Rα by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:4344.
64. Cash, E., A. Minty, P. Ferrara, D. Caput. D. Fradelizi, and O. Rott. 1994. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153:4258.
65. Toole, B. P. 1982. Developmental role of hyaluronate. Connect. Tissue Res. 10: 93.
66. Noble, P. W., C. M. McKee, M. Cowman, and H. S. Shin. 1996. Hyaluronan fragments activate an NF-κB/I-κB autoregulatory loop in murine macrophages. J. Exp. Med. 183:2373.
67. Henderson, E. B., M. Grootveld, A. Farrell, E. C. Smith, P. W. Thompson, and D. R. Blake. 1991. A pathological role for damaged hyaluronan in synovitis. Ann. Rheum. Dis. 50:196.
68. Udani, M., N. Rao, and M. J. Telen. 1997. Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction. Transfusion. 37:904.
69. Hoffman, M. 1991. Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incomplete transfusions. Vox Sang. 60:184.
70. Davidson, J. M. 1992. Wound repair. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin. I. M. Goldstein, and R. Synderman, eds. Raven Press, Ltd., New York, p. 809.
71. Riches, D. W. H. 1996. Macrophage involvement in wound repair, remodeling, and fibrosis. In The Molecular and Cellular Biology of Wound Repair, 2nd Ed. Richard A. F. Clark, ed. Plenum Press, New York, p. 95.
72. Buchanan, K. L., and J. W. Murphy. 1997. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 90:189.